Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer. - Wikidata - awgldk - TriplyDB

Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer.

Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer.

http://www.wikidata.org/entity/Q37201832

about

Bacteria in Cancer Therapy: Renaissance of an Old Concept Tumor endothelial cells Regional hyperthermia added to intensified preoperative chemo-radiation in locally advanced adenocarcinoma of middle and lower rectum.Polysilsesquioxane nanoparticles for triggered release of cisplatin and effective cancer chemoradiotherapy Customizing systemic therapy in patients with advanced non-small cell lung cancer.Use of S-100B to evaluate therapy effects during bevacizumab induction treatment in AJCC stage III melanoma.Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy.VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects.Antiangiogenics: the potential role of integrating this novel treatment modality with chemoradiation for solid cancers.Targeted therapy in rectal cancer.Correlation between tumor growth delay and expression of cancer and host VEGF, VEGFR2, and osteopontin in response to radiotherapy.Current status of antivascular therapy and targeted treatment in the clinic.Clinical biomarkers of angiogenesis inhibition.Multidisciplinary treatment of resectable rectal cancer.Tumor vasculature as target for therapeutic intervention.Jekyll and Hyde: the role of the microenvironment on the progression of cancer.Complete pathologic response after combined modality treatment for rectal cancer and long-term survival: a meta-analysis.The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma.Treatment outcomes regarding the addition of targeted agents in the therapeutic portfolio for stage II-III rectal cancer undergoing neoadjuvant chemoradiation.

P2860

Q26751222-498C85E3-8237-4902-B263-58D8B82D7D39 Q26995733-EE783BAA-F49F-42B0-B429-A0B62D309351 Q34098024-9A5FCE22-C5CD-4743-8AE6-32DE72F11CAD Q34791190-6005C8E8-CDA8-4F28-8990-2390D5A78449 Q35146940-2400A278-B0D7-4B61-A4D1-00D5BDBC69F6 Q35691033-A9A7BF7A-2481-4D24-9566-251CE600FA48 Q36614764-A568D476-189E-43D4-89A7-7D9653038196 Q36803200-A63FCCB3-8BBD-4DE9-9FC4-2486AE3453D4 Q36935068-789D41E4-48EA-43D7-93DB-CDA683EC7233 Q36957757-E23E0BF4-2ED2-4D19-BC8F-7FB159A92042 Q36978021-769FF5EC-175A-4C90-9310-51F1FE1CDEA5 Q37063510-5A9C2706-E4C2-4CD5-A3F4-BD2FB97DDEF2 Q37139413-71D8A0ED-575B-40B0-83DF-3BE8E524CAA5 Q37578503-4423E3DC-4CFC-4389-B77D-1EDEFC47A693 Q37800110-FE016FE7-866A-4B6F-995E-CEBDDE253E3D Q37815128-B173A7F8-9A25-40B2-AE22-49C9075FDF56 Q37995506-3FC3C0A4-D98D-46F1-9EEE-5CF81A438E9C Q46037079-34313961-A5FC-4C95-BD94-152AF8D8CB9A Q49381573-D093BD73-7E22-4A8D-A29B-BD9E3E3E882A

P2860

Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer.

http://www.wikidata.org/entity/Q37201832

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Complete pathological response ...... ion in advanced rectal cancer.

@en

Complete pathological response ...... ion in advanced rectal cancer.

@nl

type

label

Complete pathological response ...... ion in advanced rectal cancer.

@en

Complete pathological response ...... ion in advanced rectal cancer.

@nl

prefLabel

Complete pathological response ...... ion in advanced rectal cancer.

@en

Complete pathological response ...... ion in advanced rectal cancer.

@nl

P1433

Q37201832-DA142CD4-3C19-4493-94EF-EFB085809508

P1476

Q37201832-9024A5ED-A657-4A7C-BBFA-9EE4EF167241

P2093

Q37201832-105E43D0-93D8-4280-BA12-36AF1E26DABE

Q37201832-324A28CD-0780-4265-B70D-2680CADDD1C0

Q37201832-4F6CD8CE-1A66-478E-95EF-E85529449A15

Q37201832-59894398-58CB-4E02-B798-AF2178E95EF5

Q37201832-78BF0E21-F992-42ED-9F8A-E7580786322D

Q37201832-80C9678C-9817-4813-9F24-C59B5CE5771F

Q37201832-989E83EA-E516-4549-BDA1-6103188C9A1E

Q37201832-9BBE7F37-AADF-41DD-9083-29E94A8FE5CA

Q37201832-9F9E6568-E150-43EE-AF53-41DFC3164BED

Q37201832-AA8846C4-5F40-4B51-B436-319E7F550E26

P2860

Q37201832-3D892272-29A8-438D-8955-5835E1D0A464

Q37201832-46B3CBA0-209A-400B-B3CF-6AF2E986D372

Q37201832-49188638-5F0B-4EDE-BF27-C8548856530F

Q37201832-4AFED2F0-5203-4710-BB7C-1CF09C7E5BBC

Q37201832-55EF8D46-77A7-4C70-8236-5238E61C8AB6

Q37201832-613FC929-EE05-417B-A9CF-29CD9F0CA838

Q37201832-6A7C5065-D741-4F2A-AAF8-AC838EA977EA

Q37201832-8C7843F5-AD25-425A-9A23-4A68D68220A1

Q37201832-B163AC2B-49DE-4968-B905-456ED4362CB5

Q37201832-B8976069-193A-43D0-B475-AE2EB33429A2

P304

Q37201832-55525003-08D6-43AE-BD92-B081BBDE43E8

P31

Q37201832-FEE13B6F-0739-4120-9B09-AF944C1CAEC7

P356

Q37201832-BF87C7D6-E2D0-43F5-B3F7-D1B9734EF886

P433

Q37201832-AE457443-8730-4595-8346-957CE9A2B96D

P478

Q37201832-987498C0-26F7-43FA-9908-E8F30A0D732F

P577

Q37201832-CED426E1-459F-42EC-B1F1-AFA3F4417951

P5875

Q37201832-A7633337-B9CC-4210-BE01-A945B5D96710

P698

Q37201832-9CFC0C24-EBC9-4FDC-85AF-AE1FD3F59B17

P921

Q37201832-BABC9AEA-D440-4544-9638-1FCA55D42D0E

Q37201832-DA853474-8E98-4628-9344-DE108344F135

P932

Q37201832-F4DAEC62-146C-43C6-9232-766989098D9B

P356

P1433

Nature Clinical Practice Oncology

P1476

Complete pathological response ...... ion in advanced rectal cancer.

@en

P2093

Brian G Czito

http://www.w3.org/2001/XMLSchema#string

Christopher G Willett

http://www.w3.org/2001/XMLSchema#string

Dan G Duda

http://www.w3.org/2001/XMLSchema#string

Emmanuelle di Tomaso

http://www.w3.org/2001/XMLSchema#string

Erik Paulson

http://www.w3.org/2001/XMLSchema#string

Gordana Vlahovic

http://www.w3.org/2001/XMLSchema#string

Gregory Y Lauwers

http://www.w3.org/2001/XMLSchema#string

Herbert I Hurwitz

http://www.w3.org/2001/XMLSchema#string

Johanna Bendell

http://www.w3.org/2001/XMLSchema#string

Kenneth S Cohen

http://www.w3.org/2001/XMLSchema#string

P2860

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer

Cancer statistics, 2007

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

Efficacy of routine preoperative computed tomography scans in colon cancer.

Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study

Lessons from phase III clinical trials on anti-VEGF therapy for cancer.

A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood.

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

The utility of pre-operative abdominal computerized tomography scanning in colorectal surgery.

Preoperative staging of rectal cancer by intrarectal ultrasound.

P304

316-321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCPONC0813

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2007-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6365649

http://www.w3.org/2001/XMLSchema#string

P698

17464339

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

2686127

http://www.w3.org/2001/XMLSchema#string